← Open Payments lookup

COLLEEN LINDLEAF: Open Payments

NPI 1417376781 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,005 in 99 payments from 18 companies in 2025. Trend: 2023 $38 · 2024 $1,267 · 2025 $2,005

Food & beverage: $2,005
CompanyPaymentsAmount
ABBVIE INC.19$401
AstraZeneca Pharmaceuticals LP15$331
Amgen Inc.12$220
PFIZER INC.10$194
Novo Nordisk Inc9$191
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$142
GlaxoSmithKline, LLC.7$137
Otsuka America Pharmaceutical, Inc.3$67
Lilly USA, LLC3$61
Exact Sciences Corporation3$49

Products named: VRAYLAR, BREZTRI, NURTEC ODT, CAPLYTA, OTEZLA, FARXIGA, Wegovy, KRYSTEXXA.

Industry payments across NV — which companies pay providers there.